In 2026, the legal landscape for THC weed (tetrahydrocannabinol) in Europe remains complex and fragmented. At the EU level, THC is unequivocally classified as a drug, but member states have developed widely different national approaches, from decriminalization to strict prohibition. This guide explains the EU legal framework, recent developments, and what the patchwork of national laws means for consumers and businesses.

EU Classification: THC is a Controlled Substance

At the European level, THC is considered a drug. Council Framework Decision 2004/757/JHA defines THC as a drug and requires trafficking in it to be punishable as a crime . This is based on THC’s inclusion in the 1971 United Nations Convention on Psychotropic Substances .

The EU’s commitment to this classification was underscored in a landmark January 2026 ruling by the European Court of Justice. The Court found that Hungary failed to fulfil its EU obligations by voting against the EU’s agreed position on cannabis scheduling at the UN Commission on Narcotic Drugs . This case affirmed the principle of sincere cooperation and confirmed that the EU has exclusive external competence on drug scheduling matters that could affect common EU rules .

The EU Hemp Rules: THC Limits for Agriculture

While THC itself is a controlled substance, EU agricultural law provides a carve-out for industrial hemp. Under Regulation (EU) 2021/2115, hemp cultivated for agricultural purposes must have a Δ9-THC content not exceeding 0.3% . Proposed new rules expected by late 2026 or early 2027 would extend this 0.3% THC limit to all exported hemp plant parts, including raw hemp and seeds .

However, this agricultural exception does not legalize the sale or use of THC. A Danish government response in June 2025 confirmed that no EU regulation exists governing the cultivation, production, use, and sale of THC or THCA at the EU level outside agricultural contexts .

Pending Legal Challenges: The Cross-Border Issue

A crucial legal question is pending before the European Court of Justice in Case C-73/26 (referred by the Dutch Supreme Court in February 2026) . The Court will decide whether EU law prevents member states from banning the possession and importation of hemp from other EU countries when:

  • It is cultivated from a variety in the EU’s common catalogue
  • Its THC content is ≤0.3%

This case will clarify whether national bans on low-THC hemp violate the EU’s free movement of goods principles and could significantly reshape cross-border trade in hemp and low-THC cannabis products .

National Approaches: A Patchwork of Laws

Despite the EU’s classification of THC as a drug, member states have taken divergent approaches to enforcement .

Decriminalization and Legal Access Models

  • Germany has legalized possession of up to 25g in public and established non-profit cannabis social clubs where members can access THC.
  • Czechia decriminalized possession of up to 25g from January 2026.
  • Malta legalized possession of up to 7g and non-profit cannabis associations.
  • Netherlands operates a tolerated coffeeshop system, though THC sale is officially illegal but not prosecuted under certain conditions .

Medical Cannabis

Medical cannabis containing THC is legal in over 14 European countries, including Germany, Italy, Poland, the Netherlands, and the UK . The European medical cannabis market is projected to reach 3.2 billion euros by 2025 . Cannabis-derived medicinal products can be authorized via standard EU pharmaceutical procedures, and the EMA is working to establish guidelines .

Countries with Strict Prohibition

Many EU countries, including France, Denmark, Sweden, and Finland, maintain strict prohibition with penalties including incarceration for possession . THC vapes, in particular, have been identified by the European Commission as a growing illegal trend on the internal market .

Consequences for CBD Products

The legal status of THC has a direct impact on the CBD industry. Most European countries limit THC in CBD products to 0.2–0.3% . Products exceeding these limits are classified as illegal drugs, even if they are primarily CBD. The EU Novel Food regulation also classifies CBD extracts as requiring authorization before marketing, creating additional hurdles .

Conclusion

In 2026, THC in Europe remains classified as a controlled substance at the EU level, but national enforcement varies dramatically. Germany and Czechia have moved toward legalization and decriminalization, while many countries maintain strict prohibition. The 0.3% THC threshold for industrial hemp is under legal challenge, with a pending ECJ case (C-73/26) likely to clarify cross-border rules. For consumers, the key takeaway is that local laws determine access and penalties vary significantly across the continent.